OpenMol/LPM-24_caption_extra-SFT · Datasets at Hugging Face

instruction stringlengths 26 882	output stringlengths 5 2.09k	input stringclasses 1 value
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC The above is a compound. Could you please tell me something about it?	The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both barth syndrome and diabetic heart disease. The molecule is a surfactant and a membrane stabilizer, it impacts aging, and is smooth. The molecule is a nutritional supplement, energy source, apoptosis, cholesterol translocation that impacts tangier disease. The molecule is a food additive, energy storage, stabilizing mitochondrial structure, emulsifier that impacts non-alcoholic fatty liver disease.
Describe this molecule: CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC	The molecule is a stabilizing cytochrome oxidase, a energy source, and a surfactant, and it impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation, nutritional supplement. The molecule is a food additive that impacts aging, tangier disease, and barth syndrome. The molecule is a apoptosis, a energy storage, and a emulsifier, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a membrane stabilizer.
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC What do you know about the molecule?	The molecule is a apoptosis. The molecule is a emulsifier and a food additive, it impacts non-alcoholic fatty liver disease, and is smooth. The molecule is a stabilizing mitochondrial structure, membrane stabilizer, cholesterol translocation, proton trap for oxidative phosphorylation. The molecule is a nutritional supplement that impacts diabetic heart disease, aging, and tangier disease. The molecule is a surfactant, stabilizing cytochrome oxidase, energy storage, energy source that impacts barth syndrome.
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC	The molecule is a nutritional supplement, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, surfactant that impacts tangier disease. The molecule is a membrane stabilizer and a emulsifier, which impacts non-alcoholic fatty liver disease, barth syndrome, and aging, and is characterized as smooth. The molecule is a food additive, a energy storage, and a cholesterol translocation. The molecule is a apoptosis, a stabilizing cytochrome oxidase, and a energy source, and it impacts diabetic heart disease.
Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC . Please describe it in natural language.	The molecule is a nutritional supplement, a membrane stabilizer, and a stabilizing cytochrome oxidase, it impacts aging and is smooth. The molecule is a surfactant, energy source, energy storage, food additive that impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation, impacting both tangier disease and diabetic heart disease. The molecule is a apoptosis, a stabilizing mitochondrial structure, and a emulsifier, and it impacts non-alcoholic fatty liver disease.
Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC	The molecule is a apoptosis that impacts aging, barth syndrome, and tangier disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is both a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase.
Please give me some details about this molecule. CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC	The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and tangier disease.
What can you tell me about this molecule? CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC	The molecule is a stabilizing mitochondrial structure and apoptosis, and it impacts tangier disease. The molecule is a cholesterol translocation that impacts diabetic heart disease, aging, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease.
CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC What do you know about the molecule?	The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both tangier disease and aging. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease.
Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC	The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation, impacting both aging and non-alcoholic fatty liver disease.
CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O The above is a compound. Could you please tell me something about it?	The molecule is both a protein kinase inhibitor and a kinase inhibitor.
May I have a capsulized explanation for this molecule? CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O	The molecule is both a kinase inhibitor and a protein kinase inhibitor.
Can you briefly describe the molecular encoded by this SMILES notation? CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O	The molecule is both a protein kinase inhibitor and a kinase inhibitor.
Tell me something about this molecule: CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O	The molecule is both a protein kinase inhibitor and a kinase inhibitor.
Describe this molecule: CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O	The molecule is both a protein kinase inhibitor and a kinase inhibitor.
I need a brief explanation of the molecule denoted in this SMILES notation. COc1cc(C)cc2ncc(C(C)C)nc12	The molecule is a fxr agonist.
Please give me some details about this molecule. COc1cc(C)cc2ncc(C(C)C)nc12	It belongs to the fxr agonist class of molecules.
COc1cc(C)cc2ncc(C(C)C)nc12 The above is a compound. Could you please tell me something about it?	The molecule is a fxr agonist.
May I have a capsulized explanation for this molecule? COc1cc(C)cc2ncc(C(C)C)nc12	The molecule is a fxr agonist.
Describe this molecule: COc1cc(C)cc2ncc(C(C)C)nc12	The molecule is a fxr agonist.
Please provide a brief introduction to this molecule. Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O	The molecule is a neurological treatment.
I need a brief explanation of the molecule denoted in this SMILES notation. Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O	The molecule is a neurological treatment.
I need a brief explanation of the molecule denoted in this SMILES notation. Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O	It belongs to the neurological treatment class of molecules.
Can you briefly describe the molecular encoded by this SMILES notation? Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O	The molecule is a neurological treatment.
Tell me something about this molecule: Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O	It impacts neurological treatment.
I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC	The molecule is a stabilizing mitochondrial structure that impacts tangier disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a cholesterol translocation and a apoptosis, impacting both barth syndrome and aging.
CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC The above is a compound. Could you please tell me something about it?	The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase, impacting both tangier disease and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a apoptosis, impacting both barth syndrome and aging. The molecule is a cholesterol translocation that impacts non-alcoholic fatty liver disease.
Could you give me a brief introduction to this molecule? CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC	The molecule is a stabilizing cytochrome oxidase that impacts both aging and barth syndrome. The molecule is a cholesterol translocation and stabilizing mitochondrial structure, and it impacts diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and tangier disease.
Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC . Please describe it in natural language.	The molecule is a apoptosis that impacts both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and cholesterol translocation, and it impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase, impacting both aging and tangier disease.
Could you give me a brief introduction to this molecule? CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC	The molecule is a proton trap for oxidative phosphorylation, a cholesterol translocation, and a stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease. The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, diabetic heart disease, and aging.
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC	The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, barth syndrome, and aging.
What can you tell me about this molecule? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC	The molecule is a proton trap for oxidative phosphorylation. The molecule is a cholesterol translocation that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis that impacts aging and non-alcoholic fatty liver disease.
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC The above is a compound. Could you please tell me something about it?	The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease. The molecule is a apoptosis that impacts non-alcoholic fatty liver disease, diabetic heart disease, and aging.
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC The above is a compound. Could you please tell me something about it?	The molecule is a stabilizing mitochondrial structure that impacts both diabetic heart disease and tangier disease. The molecule is a proton trap for oxidative phosphorylation, a apoptosis, and a cholesterol translocation, and it impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts both non-alcoholic fatty liver disease and aging.
Please give me some details about this molecule. CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC	The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and barth syndrome. The molecule is a apoptosis, stabilizing cytochrome oxidase, cholesterol translocation that impacts diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure.
Can you briefly describe the molecular encoded by this SMILES notation? CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	The molecule is a nutrient that impacts pancreatitis, thyroxine treatment, and atherosclerosis. The molecule is a fat storage that impacts both cardiovascular disease and metabolic syndrome.
Can you briefly describe the molecular encoded by this SMILES notation? CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	The molecule is a member of the thyroxine treatment class and affects both atherosclerosis and cardiovascular disease. The molecule is a nutrient and a fat storage, impacting both metabolic syndrome and pancreatitis.
Tell me something about this molecule: CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	The molecule is a nutrient and fat storage, belonging to the thyroxine treatment class of molecules, and impacts atherosclerosis, pancreatitis, and metabolic syndrome. It impacts cardiovascular disease.
Could you give me a brief introduction to this molecule? CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	The molecule is thyroxine treatment and it impacts both cardiovascular disease and metabolic syndrome. The molecule is a nutrient and a fat storage, impacting both pancreatitis and atherosclerosis.
CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC The above is a compound. Could you please tell me something about it?	It impacts atherosclerosis. The molecule is a nutrient, thyroxine treatment, fat storage that impacts metabolic syndrome, cardiovascular disease, and pancreatitis.
I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is a stabilizing mitochondrial structure and proton trap for oxidative phosphorylation, and it impacts non-alcoholic fatty liver disease. The molecule is a cholesterol translocation that impacts aging, barth syndrome, and diabetic heart disease. The molecule is a apoptosis and stabilizing cytochrome oxidase, and it impacts tangier disease.
I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	It impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. The molecule is a apoptosis and proton trap for oxidative phosphorylation, and it impacts barth syndrome. The molecule is a cholesterol translocation, a stabilizing mitochondrial structure, and a stabilizing cytochrome oxidase, and it impacts tangier disease.
Describe this molecule: CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts non-alcoholic fatty liver disease, aging, barth syndrome, and tangier disease. The molecule is a cholesterol translocation, a proton trap for oxidative phosphorylation, and a stabilizing cytochrome oxidase, and it impacts diabetic heart disease.
Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both barth syndrome and aging. The molecule is a stabilizing mitochondrial structure that impacts tangier disease.
Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is a stabilizing cytochrome oxidase and cholesterol translocation, and it impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure, impacting both aging and tangier disease. The molecule is a apoptosis that impacts both barth syndrome and diabetic heart disease.
May I have a capsulized explanation for this molecule? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34	The molecule is a nutrient.
Please give me some details about this molecule. COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34	The molecule is a nutrient.
May I have a capsulized explanation for this molecule? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34	The molecule is a nutrient.
Can you briefly describe the molecular encoded by this SMILES notation? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34	The molecule is a nutrient.
I'd like a short overview about this molecule. Can you do that? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34	The molecule is a nutrient.
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC	The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a apoptosis, and it impacts tangier disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. It impacts aging.
May I have a capsulized explanation for this molecule? CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC	It impacts diabetic heart disease, barth syndrome, aging, and tangier disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease. The molecule is a apoptosis.
Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC . Please describe it in natural language.	The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation that impacts diabetic heart disease, aging, barth syndrome, and tangier disease.
I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC	The molecule is a cholesterol translocation and apoptosis, and it impacts barth syndrome. It impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, a stabilizing mitochondrial structure, and a proton trap for oxidative phosphorylation, and it impacts aging.
May I have a capsulized explanation for this molecule? CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC	The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging.
Could you give me a brief introduction to this molecule? CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC	It has an effect on colorectal cancer, and impacts seizure, parkinson's disease, alzheimer's disease, breast cancer, and cardiovascular disease. It impacts both stomach cancer and diabetes mellitus.
I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC	It has an effect on stomach cancer, colorectal cancer, and impacts diabetes mellitus, alzheimer's disease, cardiovascular disease. It impacts seizure, breast cancer, and parkinson's disease.
I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC	It impacts diabetes mellitus, alzheimer's disease, colorectal cancer, and cardiovascular disease. It has an effect on stomach cancer, and impacts parkinson's disease, breast cancer, and seizure.
Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC . Please describe it in natural language.	It has an effect on colorectal cancer, and impacts alzheimer's disease, cardiovascular disease, diabetes mellitus, and stomach cancer. It has an effect on breast cancer, impacting both seizure and parkinson's disease.
Can you briefly describe the molecular encoded by this SMILES notation? CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC	It has an effect on stomach cancer, and impacts cardiovascular disease, alzheimer's disease, and colorectal cancer. It has an effect on breast cancer, and impacts seizure, parkinson's disease, and diabetes mellitus.
What can you tell me about this molecule? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC	The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts aging and diabetic heart disease.
Could you give me a brief introduction to this molecule? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC	The molecule is a stabilizing mitochondrial structure that impacts both tangier disease and aging. The molecule is a apoptosis and stabilizing cytochrome oxidase, and it impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation, impacting both diabetic heart disease and non-alcoholic fatty liver disease.
May I have a capsulized explanation for this molecule? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC	The molecule is a cholesterol translocation and a apoptosis, impacting both aging and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation.
Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC	The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase, impacting both diabetic heart disease and barth syndrome. The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and aging.
CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC The above is a compound. Could you please tell me something about it?	It impacts both tangier disease and aging. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, a apoptosis, and a stabilizing cytochrome oxidase, and it impacts barth syndrome.
Please provide a brief introduction to this molecule. FC(F)(F)C1CCOC2(CNC2)C1	The molecule is a alzheimer's treatment that impacts epilepsy treatment.
Can you briefly describe the molecular encoded by this SMILES notation? FC(F)(F)C1CCOC2(CNC2)C1	The molecule is a alzheimer's treatment and belongs to the epilepsy treatment class of molecules.
Could you give me a brief introduction to this molecule? FC(F)(F)C1CCOC2(CNC2)C1	The molecule is a epilepsy treatment member of the alzheimer's treatment class.
Please provide a brief introduction to this molecule. FC(F)(F)C1CCOC2(CNC2)C1	The molecule is alzheimer's treatment and epilepsy treatment.
What can you tell me about this molecule? FC(F)(F)C1CCOC2(CNC2)C1	The molecule is both a alzheimer's treatment and a epilepsy treatment.
Tell me something about this molecule: CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC	The molecule is a proton trap for oxidative phosphorylation, a stabilizing mitochondrial structure, and a stabilizing cytochrome oxidase, and it impacts aging. The molecule is a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. The molecule is a cholesterol translocation.
Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC . Please describe it in natural language.	The molecule is a stabilizing mitochondrial structure and a apoptosis, impacting both non-alcoholic fatty liver disease and aging. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase.
Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC	The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation, impacting both aging and tangier disease.
Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC . Please describe it in natural language.	The molecule is a stabilizing cytochrome oxidase and a apoptosis, impacting both aging and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a cholesterol translocation.
Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC	It impacts aging, non-alcoholic fatty liver disease, tangier disease, and barth syndrome. The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease.
What can you tell me about this molecule? CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC	The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase that impacts aging, barth syndrome, diabetic heart disease, and tangier disease.
Tell me something about this molecule: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC	The molecule is a cholesterol translocation and stabilizing mitochondrial structure, and it impacts diabetic heart disease. It impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, a proton trap for oxidative phosphorylation, and a stabilizing cytochrome oxidase, and it impacts aging.
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC	The molecule is both a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation. The molecule is a stabilizing cytochrome oxidase that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a apoptosis and a cholesterol translocation, impacting both aging and barth syndrome.
Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC . Please describe it in natural language.	The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a stabilizing mitochondrial structure, a stabilizing cytochrome oxidase, and a proton trap for oxidative phosphorylation, and it impacts diabetic heart disease.
Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC . Please describe it in natural language.	It impacts both aging and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation that impacts diabetic heart disease, tangier disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase, cholesterol translocation.
Here is a molecule represented with SMILE: CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C . Please describe it in natural language.	The molecule is a energy storage, a stabilizing mitochondrial structure, and a food additive, and it impacts tangier disease. The molecule is a proton trap for oxidative phosphorylation and a nutritional supplement, impacting both aging and barth syndrome. The molecule is a surfactant, a stabilizing cytochrome oxidase, and a membrane stabilizer, and it impacts non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, a energy source, and a emulsifier, and it impacts diabetic heart disease. The molecule is a apoptosis and is smooth.
I'd like a short overview about this molecule. Can you do that? CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is a stabilizing cytochrome oxidase, energy source, surfactant, emulsifier, proton trap for oxidative phosphorylation that impacts tangier disease. The molecule is a apoptosis, food additive, stabilizing mitochondrial structure, membrane stabilizer that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a cholesterol translocation, a energy storage, and a nutritional supplement that impacts both aging and barth syndrome, and is smooth.
Tell me something about this molecule: CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is a nutritional supplement and a stabilizing cytochrome oxidase, it impacts tangier disease, and is smooth. The molecule is a surfactant and apoptosis, and it impacts non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a emulsifier, impacting both barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, a energy source, and a energy storage. The molecule is a membrane stabilizer, a proton trap for oxidative phosphorylation, and a food additive, and it impacts aging.
I'd like a short overview about this molecule. Can you do that? CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is a energy source and a energy storage, which impacts barth syndrome, aging, and non-alcoholic fatty liver disease, and is characterized as smooth. The molecule is a surfactant, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, membrane stabilizer, emulsifier that impacts tangier disease. The molecule is a stabilizing mitochondrial structure, food additive, cholesterol translocation, nutritional supplement, apoptosis that impacts diabetic heart disease.
May I have a capsulized explanation for this molecule? CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	The molecule is both a stabilizing mitochondrial structure and a apoptosis. The molecule is a emulsifier and a cholesterol translocation, impacting both barth syndrome and tangier disease. The molecule is a nutritional supplement, a surfactant, a energy source, and smooth. The molecule is a proton trap for oxidative phosphorylation, a membrane stabilizer, and a food additive, and it impacts diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a energy storage, impacting both non-alcoholic fatty liver disease and aging.
Can you briefly describe the molecular encoded by this SMILES notation? CC1C(=O)c2ccccc2C(CCNOCc2ccccc2)C1=C=O	The molecule is a aldose reductase inhibitor.
May I have a capsulized explanation for this molecule? CC1C(=O)c2ccccc2C(CCNOCc2ccccc2)C1=C=O	The molecule is a aldose reductase inhibitor.
Tell me something about this molecule: CC1C(=O)c2ccccc2C(CCNOCc2ccccc2)C1=C=O	The molecule is a aldose reductase inhibitor.
Describe this molecule: CC1C(=O)c2ccccc2C(CCNOCc2ccccc2)C1=C=O	The molecule is a aldose reductase inhibitor.
What can you tell me about this molecule? CC1C(=O)c2ccccc2C(CCNOCc2ccccc2)C1=C=O	The molecule is a aldose reductase inhibitor.
What can you tell me about this molecule? CCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC	The molecule is a apoptosis, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease, tangier disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and aging.
Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC	It impacts both aging and barth syndrome. The molecule is a stabilizing mitochondrial structure, a cholesterol translocation, and a stabilizing cytochrome oxidase, and it impacts diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and tangier disease.
I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC	It impacts tangier disease, aging, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and proton trap for oxidative phosphorylation, and it impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure, a apoptosis, and a stabilizing cytochrome oxidase, and it impacts barth syndrome.
CCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC What do you know about the molecule?	The molecule is a apoptosis that impacts both diabetic heart disease and tangier disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and barth syndrome. The molecule is a stabilizing mitochondrial structure and stabilizing cytochrome oxidase, and it impacts aging.
May I have a capsulized explanation for this molecule? CCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC	The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease. The molecule is a stabilizing mitochondrial structure that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease.
Could you give me a brief introduction to this molecule? CCC(C)CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C	The molecule is a fat storage and a membrane stabilizer, impacting both cardiovascular disease and metabolic syndrome. The molecule is a thyroxine treatment, a nutrient, and a energy storage, and it impacts cancer. The molecule is a inflammatory and a energy source that impacts pancreatitis, atherosclerosis, and obesity.
Please give me some details about this molecule. CCC(C)CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C	The molecule is a inflammatory and energy source, and it impacts cancer. The molecule is a energy storage and a nutrient that impacts atherosclerosis, thyroxine treatment, and obesity. The molecule is a fat storage and a membrane stabilizer that impacts pancreatitis, metabolic syndrome, and cardiovascular disease.
CCC(C)CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C What do you know about the molecule?	The molecule is a membrane stabilizer and thyroxine treatment, impacting cancer, metabolic syndrome, atherosclerosis, and obesity. The molecule is a energy source and nutrient, and it impacts pancreatitis. The molecule is a inflammatory, a fat storage, and a energy storage, and it impacts cardiovascular disease.
Can you briefly describe the molecular encoded by this SMILES notation? CCC(C)CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C	The molecule is a membrane stabilizer. The molecule is a energy source, nutrient, fat storage that belongs to the thyroxine treatment class of molecules and impacts both obesity and atherosclerosis. The molecule is a inflammatory and energy storage, affecting cancer, and impacting cardiovascular disease, pancreatitis, and metabolic syndrome.
Please give me some details about this molecule. CCC(C)CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C	The molecule is a energy storage, nutrient, membrane stabilizer, energy source that impacts atherosclerosis and thyroxine treatment. The molecule is a fat storage that impacts both metabolic syndrome and pancreatitis. The molecule is a inflammatory that affects cancer by impacting both cardiovascular disease and obesity.

CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC The above is a compound. Could you please tell me something about it?

The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both barth syndrome and diabetic heart disease. The molecule is a surfactant and a membrane stabilizer, it impacts aging, and is smooth. The molecule is a nutritional supplement, energy source, apoptosis, cholesterol translocation that impacts tangier disease. The molecule is a food additive, energy storage, stabilizing mitochondrial structure, emulsifier that impacts non-alcoholic fatty liver disease.

Describe this molecule: CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC

The molecule is a stabilizing cytochrome oxidase, a energy source, and a surfactant, and it impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation, nutritional supplement. The molecule is a food additive that impacts aging, tangier disease, and barth syndrome. The molecule is a apoptosis, a energy storage, and a emulsifier, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a membrane stabilizer.

CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC What do you know about the molecule?

The molecule is a apoptosis. The molecule is a emulsifier and a food additive, it impacts non-alcoholic fatty liver disease, and is smooth. The molecule is a stabilizing mitochondrial structure, membrane stabilizer, cholesterol translocation, proton trap for oxidative phosphorylation. The molecule is a nutritional supplement that impacts diabetic heart disease, aging, and tangier disease. The molecule is a surfactant, stabilizing cytochrome oxidase, energy storage, energy source that impacts barth syndrome.

I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC

The molecule is a nutritional supplement, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, surfactant that impacts tangier disease. The molecule is a membrane stabilizer and a emulsifier, which impacts non-alcoholic fatty liver disease, barth syndrome, and aging, and is characterized as smooth. The molecule is a food additive, a energy storage, and a cholesterol translocation. The molecule is a apoptosis, a stabilizing cytochrome oxidase, and a energy source, and it impacts diabetic heart disease.

Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC . Please describe it in natural language.

The molecule is a nutritional supplement, a membrane stabilizer, and a stabilizing cytochrome oxidase, it impacts aging and is smooth. The molecule is a surfactant, energy source, energy storage, food additive that impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation, impacting both tangier disease and diabetic heart disease. The molecule is a apoptosis, a stabilizing mitochondrial structure, and a emulsifier, and it impacts non-alcoholic fatty liver disease.

Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC

The molecule is a apoptosis that impacts aging, barth syndrome, and tangier disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is both a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase.

Please give me some details about this molecule. CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC

The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and tangier disease.

What can you tell me about this molecule? CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC

The molecule is a stabilizing mitochondrial structure and apoptosis, and it impacts tangier disease. The molecule is a cholesterol translocation that impacts diabetic heart disease, aging, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease.

CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC What do you know about the molecule?

The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both tangier disease and aging. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease.

Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC

The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation, impacting both aging and non-alcoholic fatty liver disease.

CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O The above is a compound. Could you please tell me something about it?

The molecule is both a protein kinase inhibitor and a kinase inhibitor.

May I have a capsulized explanation for this molecule? CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O

The molecule is both a kinase inhibitor and a protein kinase inhibitor.

Can you briefly describe the molecular encoded by this SMILES notation? CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O

The molecule is both a protein kinase inhibitor and a kinase inhibitor.

Tell me something about this molecule: CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O

The molecule is both a protein kinase inhibitor and a kinase inhibitor.

Describe this molecule: CC(C)(O)CNC1CN(c2cc(C#N)cc(Nc3nc(NC4CC4)c4ncc(C#N)n4n3)c2Cl)CCC1NC(=O)O

The molecule is both a protein kinase inhibitor and a kinase inhibitor.

I need a brief explanation of the molecule denoted in this SMILES notation. COc1cc(C)cc2ncc(C(C)C)nc12

The molecule is a fxr agonist.

Please give me some details about this molecule. COc1cc(C)cc2ncc(C(C)C)nc12

It belongs to the fxr agonist class of molecules.

COc1cc(C)cc2ncc(C(C)C)nc12 The above is a compound. Could you please tell me something about it?

The molecule is a fxr agonist.

May I have a capsulized explanation for this molecule? COc1cc(C)cc2ncc(C(C)C)nc12

The molecule is a fxr agonist.

Describe this molecule: COc1cc(C)cc2ncc(C(C)C)nc12

The molecule is a fxr agonist.

Please provide a brief introduction to this molecule. Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O

The molecule is a neurological treatment.

I need a brief explanation of the molecule denoted in this SMILES notation. Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O

The molecule is a neurological treatment.

I need a brief explanation of the molecule denoted in this SMILES notation. Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O

It belongs to the neurological treatment class of molecules.

Can you briefly describe the molecular encoded by this SMILES notation? Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O

The molecule is a neurological treatment.

Tell me something about this molecule: Cc1cc(-c2cc(CO)ccn2)ccc1C(N)=O

It impacts neurological treatment.

I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC

The molecule is a stabilizing mitochondrial structure that impacts tangier disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a cholesterol translocation and a apoptosis, impacting both barth syndrome and aging.

CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC The above is a compound. Could you please tell me something about it?

The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase, impacting both tangier disease and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a apoptosis, impacting both barth syndrome and aging. The molecule is a cholesterol translocation that impacts non-alcoholic fatty liver disease.

Could you give me a brief introduction to this molecule? CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC

The molecule is a stabilizing cytochrome oxidase that impacts both aging and barth syndrome. The molecule is a cholesterol translocation and stabilizing mitochondrial structure, and it impacts diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and tangier disease.

Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC . Please describe it in natural language.

The molecule is a apoptosis that impacts both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and cholesterol translocation, and it impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase, impacting both aging and tangier disease.

Could you give me a brief introduction to this molecule? CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC

The molecule is a proton trap for oxidative phosphorylation, a cholesterol translocation, and a stabilizing cytochrome oxidase, and it impacts non-alcoholic fatty liver disease. The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, diabetic heart disease, and aging.

I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC

The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, barth syndrome, and aging.

What can you tell me about this molecule? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC

The molecule is a proton trap for oxidative phosphorylation. The molecule is a cholesterol translocation that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis that impacts aging and non-alcoholic fatty liver disease.

CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC The above is a compound. Could you please tell me something about it?

The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease. The molecule is a apoptosis that impacts non-alcoholic fatty liver disease, diabetic heart disease, and aging.

CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC The above is a compound. Could you please tell me something about it?

The molecule is a stabilizing mitochondrial structure that impacts both diabetic heart disease and tangier disease. The molecule is a proton trap for oxidative phosphorylation, a apoptosis, and a cholesterol translocation, and it impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts both non-alcoholic fatty liver disease and aging.

Please give me some details about this molecule. CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC

The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and barth syndrome. The molecule is a apoptosis, stabilizing cytochrome oxidase, cholesterol translocation that impacts diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure.

Can you briefly describe the molecular encoded by this SMILES notation? CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC

The molecule is a nutrient that impacts pancreatitis, thyroxine treatment, and atherosclerosis. The molecule is a fat storage that impacts both cardiovascular disease and metabolic syndrome.

Can you briefly describe the molecular encoded by this SMILES notation? CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC

The molecule is a member of the thyroxine treatment class and affects both atherosclerosis and cardiovascular disease. The molecule is a nutrient and a fat storage, impacting both metabolic syndrome and pancreatitis.

Tell me something about this molecule: CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC

The molecule is a nutrient and fat storage, belonging to the thyroxine treatment class of molecules, and impacts atherosclerosis, pancreatitis, and metabolic syndrome. It impacts cardiovascular disease.

Could you give me a brief introduction to this molecule? CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC

The molecule is thyroxine treatment and it impacts both cardiovascular disease and metabolic syndrome. The molecule is a nutrient and a fat storage, impacting both pancreatitis and atherosclerosis.

CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC The above is a compound. Could you please tell me something about it?

It impacts atherosclerosis. The molecule is a nutrient, thyroxine treatment, fat storage that impacts metabolic syndrome, cardiovascular disease, and pancreatitis.

I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is a stabilizing mitochondrial structure and proton trap for oxidative phosphorylation, and it impacts non-alcoholic fatty liver disease. The molecule is a cholesterol translocation that impacts aging, barth syndrome, and diabetic heart disease. The molecule is a apoptosis and stabilizing cytochrome oxidase, and it impacts tangier disease.

I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

It impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. The molecule is a apoptosis and proton trap for oxidative phosphorylation, and it impacts barth syndrome. The molecule is a cholesterol translocation, a stabilizing mitochondrial structure, and a stabilizing cytochrome oxidase, and it impacts tangier disease.

Describe this molecule: CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts non-alcoholic fatty liver disease, aging, barth syndrome, and tangier disease. The molecule is a cholesterol translocation, a proton trap for oxidative phosphorylation, and a stabilizing cytochrome oxidase, and it impacts diabetic heart disease.

Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both barth syndrome and aging. The molecule is a stabilizing mitochondrial structure that impacts tangier disease.

Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is a stabilizing cytochrome oxidase and cholesterol translocation, and it impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure, impacting both aging and tangier disease. The molecule is a apoptosis that impacts both barth syndrome and diabetic heart disease.

May I have a capsulized explanation for this molecule? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34

The molecule is a nutrient.

Please give me some details about this molecule. COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34

The molecule is a nutrient.

May I have a capsulized explanation for this molecule? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34

The molecule is a nutrient.

Can you briefly describe the molecular encoded by this SMILES notation? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34

The molecule is a nutrient.

I'd like a short overview about this molecule. Can you do that? COc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1OC)c2c34

The molecule is a nutrient.

I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC

The molecule is a stabilizing cytochrome oxidase, a cholesterol translocation, and a apoptosis, and it impacts tangier disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. It impacts aging.

May I have a capsulized explanation for this molecule? CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC

It impacts diabetic heart disease, barth syndrome, aging, and tangier disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease. The molecule is a apoptosis.

Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC . Please describe it in natural language.

The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation that impacts diabetic heart disease, aging, barth syndrome, and tangier disease.

I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC

The molecule is a cholesterol translocation and apoptosis, and it impacts barth syndrome. It impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, a stabilizing mitochondrial structure, and a proton trap for oxidative phosphorylation, and it impacts aging.

May I have a capsulized explanation for this molecule? CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC

The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging.

Could you give me a brief introduction to this molecule? CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC

It has an effect on colorectal cancer, and impacts seizure, parkinson's disease, alzheimer's disease, breast cancer, and cardiovascular disease. It impacts both stomach cancer and diabetes mellitus.

I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC

It has an effect on stomach cancer, colorectal cancer, and impacts diabetes mellitus, alzheimer's disease, cardiovascular disease. It impacts seizure, breast cancer, and parkinson's disease.

I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC

It impacts diabetes mellitus, alzheimer's disease, colorectal cancer, and cardiovascular disease. It has an effect on stomach cancer, and impacts parkinson's disease, breast cancer, and seizure.

Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC . Please describe it in natural language.

It has an effect on colorectal cancer, and impacts alzheimer's disease, cardiovascular disease, diabetes mellitus, and stomach cancer. It has an effect on breast cancer, impacting both seizure and parkinson's disease.

Can you briefly describe the molecular encoded by this SMILES notation? CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COP(=O)(O)OC1C(O)C(O)C(O)C(O)C1O)OC(=O)CCCC(O)C=CC=CCC=CC=CC(O)CCCCC

It has an effect on stomach cancer, and impacts cardiovascular disease, alzheimer's disease, and colorectal cancer. It has an effect on breast cancer, and impacts seizure, parkinson's disease, and diabetes mellitus.

What can you tell me about this molecule? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC

The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts aging and diabetic heart disease.

Could you give me a brief introduction to this molecule? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC

The molecule is a stabilizing mitochondrial structure that impacts both tangier disease and aging. The molecule is a apoptosis and stabilizing cytochrome oxidase, and it impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation, impacting both diabetic heart disease and non-alcoholic fatty liver disease.

May I have a capsulized explanation for this molecule? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC

The molecule is a cholesterol translocation and a apoptosis, impacting both aging and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation.

Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC

The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase, impacting both diabetic heart disease and barth syndrome. The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and aging.

CCCCCCC=CC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCCCC The above is a compound. Could you please tell me something about it?

It impacts both tangier disease and aging. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, a apoptosis, and a stabilizing cytochrome oxidase, and it impacts barth syndrome.

Please provide a brief introduction to this molecule. FC(F)(F)C1CCOC2(CNC2)C1

The molecule is a alzheimer's treatment that impacts epilepsy treatment.

Can you briefly describe the molecular encoded by this SMILES notation? FC(F)(F)C1CCOC2(CNC2)C1

The molecule is a alzheimer's treatment and belongs to the epilepsy treatment class of molecules.

Could you give me a brief introduction to this molecule? FC(F)(F)C1CCOC2(CNC2)C1

The molecule is a epilepsy treatment member of the alzheimer's treatment class.

Please provide a brief introduction to this molecule. FC(F)(F)C1CCOC2(CNC2)C1

The molecule is alzheimer's treatment and epilepsy treatment.

What can you tell me about this molecule? FC(F)(F)C1CCOC2(CNC2)C1

The molecule is both a alzheimer's treatment and a epilepsy treatment.

Tell me something about this molecule: CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC

The molecule is a proton trap for oxidative phosphorylation, a stabilizing mitochondrial structure, and a stabilizing cytochrome oxidase, and it impacts aging. The molecule is a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. The molecule is a cholesterol translocation.

Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC . Please describe it in natural language.

The molecule is a stabilizing mitochondrial structure and a apoptosis, impacting both non-alcoholic fatty liver disease and aging. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase.

Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC

The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation, impacting both aging and tangier disease.

Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC . Please describe it in natural language.

The molecule is a stabilizing cytochrome oxidase and a apoptosis, impacting both aging and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a cholesterol translocation.

Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC

It impacts aging, non-alcoholic fatty liver disease, tangier disease, and barth syndrome. The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease.

What can you tell me about this molecule? CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC

The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase that impacts aging, barth syndrome, diabetic heart disease, and tangier disease.

Tell me something about this molecule: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC

The molecule is a cholesterol translocation and stabilizing mitochondrial structure, and it impacts diabetic heart disease. It impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, a proton trap for oxidative phosphorylation, and a stabilizing cytochrome oxidase, and it impacts aging.

I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC

The molecule is both a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation. The molecule is a stabilizing cytochrome oxidase that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a apoptosis and a cholesterol translocation, impacting both aging and barth syndrome.

Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC . Please describe it in natural language.

The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a stabilizing mitochondrial structure, a stabilizing cytochrome oxidase, and a proton trap for oxidative phosphorylation, and it impacts diabetic heart disease.

Here is a molecule represented with SMILE: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC . Please describe it in natural language.

It impacts both aging and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation that impacts diabetic heart disease, tangier disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase, cholesterol translocation.

Here is a molecule represented with SMILE: CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C . Please describe it in natural language.

The molecule is a energy storage, a stabilizing mitochondrial structure, and a food additive, and it impacts tangier disease. The molecule is a proton trap for oxidative phosphorylation and a nutritional supplement, impacting both aging and barth syndrome. The molecule is a surfactant, a stabilizing cytochrome oxidase, and a membrane stabilizer, and it impacts non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, a energy source, and a emulsifier, and it impacts diabetic heart disease. The molecule is a apoptosis and is smooth.

I'd like a short overview about this molecule. Can you do that? CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is a stabilizing cytochrome oxidase, energy source, surfactant, emulsifier, proton trap for oxidative phosphorylation that impacts tangier disease. The molecule is a apoptosis, food additive, stabilizing mitochondrial structure, membrane stabilizer that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a cholesterol translocation, a energy storage, and a nutritional supplement that impacts both aging and barth syndrome, and is smooth.

Tell me something about this molecule: CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is a nutritional supplement and a stabilizing cytochrome oxidase, it impacts tangier disease, and is smooth. The molecule is a surfactant and apoptosis, and it impacts non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a emulsifier, impacting both barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, a energy source, and a energy storage. The molecule is a membrane stabilizer, a proton trap for oxidative phosphorylation, and a food additive, and it impacts aging.

I'd like a short overview about this molecule. Can you do that? CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is a energy source and a energy storage, which impacts barth syndrome, aging, and non-alcoholic fatty liver disease, and is characterized as smooth. The molecule is a surfactant, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, membrane stabilizer, emulsifier that impacts tangier disease. The molecule is a stabilizing mitochondrial structure, food additive, cholesterol translocation, nutritional supplement, apoptosis that impacts diabetic heart disease.

May I have a capsulized explanation for this molecule? CCC(C)CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C

The molecule is both a stabilizing mitochondrial structure and a apoptosis. The molecule is a emulsifier and a cholesterol translocation, impacting both barth syndrome and tangier disease. The molecule is a nutritional supplement, a surfactant, a energy source, and smooth. The molecule is a proton trap for oxidative phosphorylation, a membrane stabilizer, and a food additive, and it impacts diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a energy storage, impacting both non-alcoholic fatty liver disease and aging.

Can you briefly describe the molecular encoded by this SMILES notation? CC1C(=O)c2ccccc2C(CCNOCc2ccccc2)C1=C=O